Protein Core (William Marzluff., Faculty Director) Nucleic acid technology has evolved at an extraordinary rate and will, for all intents and purposes, complete sequencing of the human genome within the next CCSG five-year cycle. Other efforts will create substantial sequence databases from the mouse, and complete sequences are extant, or soon will be, for most lower organisms. The next era of discovery will rely much less on the sequencing of unknown nucleic acid clones, and much more on detecting and identifying proteins purified by virtue of their function or interaction with other proteins. Thus, a forward-looking core facility to identify proteins and study multiple facets of protein interactions will be of increasing importance to the UNC Lineberger. Although the CCSG has not previously funded a protein core, several components are functioning at UNC. The current proposal takes those operationalized components and combines them under one administrative structure, directed by William Marzluff, Ph.D., Cancer Center Associate Director for Core Facilities and Director for the Program of Molecular Biology and Biotechnology (PMBB). The Protein Core will include: (1) a multifaceted facility for studying biochemistry and the chemistry of protein-protein interactions; (2) a peptide synthesis facility to provide peptides for study of interactions in pure systems, as reagents to disturb cellular interactions in cell culture, and for use as antigens to raise antibodies.; (3) protein purification and peptide isolation; and (4) high sensitivity peptide sequencing, involving either Edman degradation, or, increasingly mass spectroscopy analysis of peptides.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Che, Tao; Majumdar, Susruta; Zaidi, Saheem A et al. (2018) Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor. Cell 172:55-67.e15
Hu, Peirong; Bi, Yanmin; Ma, Hong et al. (2018) Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization. Gene Ther 25:454-472
Townsley, Loni; Yannarell, Sarah M; Huynh, Tuanh Ngoc et al. (2018) Cyclic di-AMP Acts as an Extracellular Signal That Impacts Bacillus subtilis Biofilm Formation and Plant Attachment. MBio 9:
Schulfer, Anjelique F; Battaglia, Thomas; Alvarez, Yelina et al. (2018) Intergenerational transfer of antibiotic-perturbed microbiota enhances colitis in susceptible mice. Nat Microbiol 3:234-242
Hall, Marissa G; Mendel, Jennifer R; Noar, Seth M et al. (2018) Why smokers avoid cigarette pack risk messages: Two randomized clinical trials in the United States. Soc Sci Med 213:165-172
Cholon, Deborah M; Gentzsch, Martina (2018) Recent progress in translational cystic fibrosis research using precision medicine strategies. J Cyst Fibros 17:S52-S60
Tappata, Manaswita; Eluri, Swathi; Perjar, Irina et al. (2018) Association of mast cells with clinical, endoscopic, and histologic findings in adults with eosinophilic esophagitis. Allergy 73:2088-2092
Deng, Jiehui; Wang, Eric S; Jenkins, Russell W et al. (2018) CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation. Cancer Discov 8:216-233
Brenner, Alison T; Malo, Teri L; Margolis, Marjorie et al. (2018) Evaluating Shared Decision Making for Lung Cancer Screening. JAMA Intern Med 178:1311-1316
Cranston, Ross D; Cespedes, Michelle S; Paczuski, Pawel et al. (2018) High Baseline Anal Human Papillomavirus and Abnormal Anal Cytology in a Phase 3 Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Individuals Older Than 26 Years: ACTG 5298. Sex Transm Dis 45:266-271

Showing the most recent 10 out of 1525 publications